Clara cell secretory protein decreases lung inflammation after acute virus infection

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 275, Issue 5 19-5, 1998, Pages

  Harrod, Kevin S ^a   Mounday, Amber D ^a   Stripp, Barry R ^b   Whitsett, Jeffrey A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Lung epithelium; Pulmonary infection; Viral pathogenesis

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; SECRETORY PROTEIN;

ADENOVIRUS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CLARA CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; LUNG HOMOGENATE; MAMMAL; NONHUMAN; PATHOGENESIS; PEPTIDE SYNTHESIS; PNEUMONIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TRANSGENE; VIRUS INFECTION;

EID: 0031765343     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.275.5.l924     Document Type: Article

References (18)

1. Dai, Y., E. M. Schwarz, D. Gu, W. Zhang, N. Sarvetnick, and I. M. Verma. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92: 1401-1405, 1995.
2. Ginsberg, H. S., L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. A mouse model for investigating the molecular pathogenesis of adenoviral pneumonia. Proc. Natl. Acad. Sci. USA 88: 1651-1655, 1991.
3. Guerette, B., J. T. Vilquin, M. Gingras, C. Gravel, K. J. Wood, and J. P. Tremblay. Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. Hum. Gene Ther. 7: 1455-1463, 1996.
4. Hay, J. G., C. Danel, C. S. Chu, and R. G. Crystal. Human CC10 gene expression in airway epithelium and subchromosomal locus suggest linkage to airway disease. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L565-L575, 1995.
5. Johnston, C. J., G. W. Mango, J. N. Finkelstein, and B. R. Stripp. Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice. Am. J. Respir. Cell Mol. Biol. 17: 147-155, 1997.
6. Levin, S. W., J. D. Butler, U. K. Schumacher, P. D. Wightman, and A. B. Mukherjee. Uteroglobin inhibits phospholipase A2 activity. Life Sci. 38: 1813-1819, 1986.
7. Magdaleno, S. M., G. Wang, K. J. Jackson, M. K. Ray, S. Welty, R. H. Costa, and F. J. DeMayo. Interferon-γ regulation of Clara cell gene expression: in vivo and in vitro. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L1142-L1151, 1997.
8. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohm, A. Moller, H. Jacobsen, and H. Kirchner. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323: 816-819, 1986.
9. Paya, C. V., N. Kenmotsu, R. A. Schoon, and P. J. Leibson. Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J. Immunol. 141: 1989-1995, 1988.
10. Ramsay, A. J., J. Ruby, and I. A. Ramshaw. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 143: 2031-2037, 1993.
11. Singh, G., and S. L. Katyal. Clara cells and Clara cell 10 kD protein (CC10). Am. J. Respir. Cell Mol. Biol. 17: 141-143, 1997.
12. Singh, G., S. L. Katyal, W. E. Brown, and A. L. Kennedy. Mouse Clara cell 10-kDa (CC10) protein: cDNA nucleotide sequence and molecular basis for the variation in progesterone binding of CC10 from different species. Exp. Lung Res. 19: 67-75, 1993.
13. Singh, G., S. L. Katyal, W. E. Brown, A. L. Kennedy, U. Singh, and M. L. Wong-Chong. Clara cell 10 kDa protein (CC10): comparison of structure and function to uteroglobin. Biochim. Biophys. Acta 1039: 348-355, 1990.
14. Stripp, B. R., J. Lund, G. W. Mango, K. C. Doyen, C. Johnston, K. Hultenby, M. Nord, and J. A. Whitsett. Clara cell secretory protein: a determinant of PCB bioaccumulation in mammals. Am. J. Physiol. 271 (Lung Cell. Mol. Physiol. 15): L656-L664, 1996.
15. Vasanthakumar, G., R. Manjunath, A. B. Mukherjee, H. Warabi, and E. Schiffmann. Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection. Biochem. Pharmacol. 37: 389-394, 1988.
16. Vitalis, T. Z., N. Keicho, S. Itabashi, S. Hayashi, and J. C. Hogg. A model of latent adenovirus 5 infection in the guinea pig (Cairo porcellus). Am. J. Respir. Cell Mol. Biol. 14: 225-231, 1996.
17. Wright, J. R. Immunomodulatory functions of surfactant. Physiol. Rev. 77: 931-962, 1997.
18. Yang, Y., Q. Li, H. C. J. Ertl, and J. M. Wilson. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69: 2004-2015, 1995.